Free tool: see what Australians pay on PBS vs private for Ozempic, Wegovy, Mounjaro & more. July 2026 prices. Includes concession rates, Safety Net guide & eligibility.
Download on the App StoreAs of July 2026, the PBS co-payment is $25.00 per script for general patients and $7.70 per script for concession card holders (pensioners, Health Care Card holders, and certain other recipients). These amounts are reviewed quarterly and adjusted for inflation every January, April, July, and October.
On the PBS, eligible type 2 diabetes patients pay $25.00 per month (general) or $7.70 per month (concession) for Ozempic (semaglutide). Without PBS eligibility — for example, when prescribed for weight management only — Ozempic costs approximately $150–$280 per month privately. That is a potential saving of over $2,000 per year with PBS access.
No. As of July 2026, Wegovy is not PBS-listed in Australia for weight management. All patients pay the full private cost regardless of Medicare or concession status — typically $300–$500 per month depending on dose. The PBAC issued a positive recommendation in November 2025 for a narrow patient group (established cardiovascular disease + BMI ≥35), but price negotiations with Novo Nordisk are ongoing and no confirmed listing date has been announced. Check pbs.gov.au or speak to your GP for the latest status.
Mounjaro (tirzepatide) is not PBS-listed for weight management in Australia as of July 2026. Patients pay full private cost, ranging from approximately $350 per month at starter doses (2.5mg) to $500 per month at higher maintenance doses (10mg–15mg). Some patients at maximum dose report paying $600–$700 per month.
The PBS Safety Net protects Australians who need many PBS scripts in a year. For general patients, once your household's total PBS co-payment spending reaches approximately $1,613 in a calendar year, every additional PBS script for the rest of that year is free. For concession card holders, once you fill 60 PBS prescriptions in a calendar year, the rest are free. Your pharmacist tracks your Safety Net contributions automatically.
General patients pay $25.00 per PBS script (July 2026). Concession card holders — including pensioners on the Age Pension or Disability Support Pension, Commonwealth Seniors Health Card holders, and Health Care Card holders — pay $7.70 per PBS script. Concession pricing is approximately 70% cheaper. The Safety Net thresholds also differ: general patients pay until approximately $1,613 per year (after which scripts are free); concession card holders reach the Safety Net after 60 scripts per year.
Yes. PBS co-payments are indexed to the Consumer Price Index (CPI) and reviewed quarterly — updated every January, April, July, and October. Always confirm current prices at pbs.gov.au or with your pharmacist before making any medication decisions.
Search the official PBS Schedule at pbs.gov.au by medication or brand name. The Schedule shows the PBS item number, co-payment type, any authority requirements, and the approved clinical indications. Your GP or pharmacist can also confirm PBS listing and your individual eligibility based on your clinical circumstances.
Yes. The PBS co-payment is the same at any approved pharmacy — Chemist Warehouse, an independent pharmacy, a supermarket pharmacy, or a hospital outpatient pharmacy all charge the same government-set co-payment for the same PBS script. Dispensing fees may vary slightly, but the co-payment itself is fixed. You must present a valid PBS prescription from a registered Australian GP.
As of July 2026, Mounjaro (tirzepatide) is not PBS-listed for any indication in Australia. The November 2024 PBAC application was not recommended, and the listing process has since ceased. All Australians using Mounjaro — whether for weight loss or type 2 diabetes — pay full private cost, typically $250–$700 per month.